InspireMD, Inc. (NSPR) Stock Price

NSPRStock

$0.85−64.88%52W

Market Cap$39.81M

P/E—

PEG Ratio—

Div yield—

Beta0.84

NSPR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-65.98%

Price vs S&P 500 (4W)23.27%

VGM Score56.18

Book Value / Share (Quarterly)$0.93

P/TBV (Annual)3.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)20.20%

Cash Flow / Share (Quarterly)$-0.86

Price vs S&P 500 (YTD)-65.07%

Gross Margin (TTM)28.06%

Net Profit Margin (TTM)-472.98%

EPS (TTM)$-0.74

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-0.74

Revenue Growth (5Y)29.24%

EPS (Annual)$-0.76

ROI (Annual)-88.38%

Gross Margin (Annual)29.50%

Net Profit Margin (5Y Avg)-402.03%

Cash / Share (Quarterly)$0.89

Revenue Growth QoQ (YoY)61.57%

ROA (Last FY)-70.29%

Revenue Growth TTM (YoY)6.29%

EBITD / Share (TTM)$-0.71

ROE (5Y Avg)-75.66%

Operating Margin (TTM)-480.57%

Cash Flow / Share (Annual)$-0.84

P/B Ratio0.90x

P/B Ratio (Quarterly)1.75x

Net Income / Employee (Annual)$-384,100

EV / Revenue (TTM)2.58x

Net Interest Coverage (TTM)-69.08x

ROA (TTM)-86.35%

EPS Incl Extra (Annual)$-0.76

Current Ratio (Annual)5.74x

Quick Ratio (Quarterly)4.70x

3-Month Avg Trading Volume0.25M

52-Week Price Return-64.88%

Revenue / Employee (TTM)$85,400

Tangible BV / Share (Quarterly)$2.02

P/S Ratio (Annual)4.38x

Asset Turnover (Annual)0.13x

52-Week High$2.56

Operating Margin (5Y Avg)-412.06%

EPS Excl Extra (Annual)$-0.76

CapEx CAGR (5Y)79.18%

Tangible BV CAGR (5Y)42.11%

26-Week Price Return-54.05%

Quick Ratio (Annual)5.30x

13-Week Price Return-5.56%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.15x

Enterprise Value$27.99M

Revenue / Share Growth (5Y)-38.97%

Asset Turnover (TTM)0.18x

Book Value / Share Growth (5Y)-19.32%

Revenue / Employee (Annual)$70,700

Inventory Turnover (Annual)2.12x

Pretax Margin (Annual)-542.63%

Cash / Share (Annual)$1.25

3-Month Return Std Dev70.08%

Gross Margin (5Y Avg)23.69%

Net Income / Employee (TTM)$-404,000

ROE (Last FY)-88.38%

Net Interest Coverage (Annual)-11.49x

EPS Basic Excl Extra (Annual)$-0.76

Receivables Turnover (TTM)5.48x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.74

Receivables Turnover (Annual)4.80x

ROI (TTM)-112.04%

P/S Ratio (TTM)3.63x

Pretax Margin (5Y Avg)-401.17%

Revenue / Share (Annual)$0.14

Tangible BV / Share (Annual)$2.09

Price vs S&P 500 (52W)-83.43%

Year-to-Date Return-52.25%

5-Day Price Return-2.29%

EPS Normalized (Annual)$-0.76

ROA (5Y Avg)-58.61%

Net Profit Margin (Annual)-543.33%

Month-to-Date Return30.77%

Cash Flow / Share (TTM)$-0.79

EBITD / Share (Annual)$-0.76

Operating Margin (Annual)-552.56%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-75.66%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.74

P/TBV (Quarterly)1.45x

P/B Ratio (Annual)1.37x

Inventory Turnover (TTM)2.66x

Pretax Margin (TTM)-472.40%

Book Value / Share (Annual)$1.27

Price vs S&P 500 (13W)-7.51%

Beta0.84x

Revenue / Share (TTM)$0.13

ROE (TTM)-112.04%

52-Week Low$0.63

vGradeB

gGradeB

mGradeD

vgmGradeC

NSPR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$0.20	-$0.17	+15.00%(+$0.03)
Q1 2026	May 4, 2026	-$0.18	-$0.16	+11.11%(+$0.02)
Q4 2025	Mar 18, 2026	-$0.19	-$0.14	+27.58%(+$0.05)
Q3 2025	Nov 4, 2025	-$0.20	-$0.17	+12.82%(+$0.02)
Q2 2025	Aug 4, 2025	-$0.26	-$0.26	+0.00%(+$0.00)

NSPR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
NSPRInspireMD, Inc.	B	B	D	$0.85
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About InspireMD, Inc.

InspireMD is a U.S.-based medical device company specializing in proprietary MicroNet stent platform technology for treating complex vascular and coronary disease. Its primary revenue driver is the CGuard carotid Embolic Prevention System, which combines the company's proprietary MicroNet technology with a self-expandable stent for carotid artery applications. The company also offers the MGuard Prime Embolic Protection System and maintains operations across Europe and Russia.